Drug Type Monoclonal antibody |
Synonyms |
Mechanism Purinergic P2 receptor antagonists, TMEFF2 inhibitors(Tomoregulin-2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder | Preclinical | DE | 26 Jun 2009 |